⌘K
t
On 17 February 2026, NatWest Group plc purchased a total of 634,502 of its own ordinary shares, with a nominal value of £1.0769 each, from UBS AG, London Branch. These shares were bought across the LSE, CHIX, and BATE venues at prices ranging from 601.40 GBp to 617.00 GBp, as part of an existing share buyback programme. Following the transactions, NatWest Group plc holds 218,110,026 Ordinary Shares in treasury and has 7,980,521,401 Ordinary Shares in issue, with the intent to cancel the repurchased shares.
| Date | 17 Feb 2026 |
| Time | 17:36:09 |
| Category | Capital structure |
| ID | 3983T |
|
|
|
|
|
|
|
|
|
NatWest Group plc |
||||||
|
17 February 2026 |
|
|||||
|
Transaction in Own Shares |
||||||
|
NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). |
|
|||||
|
|
|
|
|
|
|
|
|
Aggregated information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of purchase |
Number of Ordinary Shares purchased |
Highest price paid: (GBp) |
Lowest price paid: (GBp) |
Volume weighted average price paid per share (GBp) |
Venue |
|
|
17 February 2026 |
475,014 |
617.00 |
601.40 |
609.02 |
LSE |
|
|
17 February 2026 |
113,432 |
616.40 |
602.40 |
609.13 |
CHIX |
|
|
17 February 2026 |
46,056 |
614.00 |
602.20 |
609.15 |
BATE |
|
|
|
|
|
|
|
|
|
|
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share |
|
|||||
|
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 16 February 2026, as announced on 16 February 2026. |
|
|||||
|
|
|
|
|
|
|
|
|
The Company intends to cancel the repurchased Ordinary Shares. |
||||||
|
|
|
|
|
|
|
|
|
Following the settlement of the above transactions, NWG will hold 218,110,026 Ordinary Shares in treasury and have 7,980,521,401 Ordinary Shares in issue (excluding treasury shares). |
|
|||||
|
|
|
|
|
|
|
|
|
Further information: |
||||||
|
|
|
|
|
|
|
|
|
Investor Relations |
|
|
|
|
|
|
|
+ 44 (0)207 672 1758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Relations |
|
|
|
|
|
|
|
+44 (0)131 523 4205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005O9XJIJN4JPN90 |
||||||
|
|
|
|
|
|
|
|
|
Transaction details: |
|
|
|
|
|
|
|
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme relating to the Transactions is detailed in the attached: |
|
|||||
http://www.rns-pdf.londonstockexchange.com/rns/3983T_1-2026-2-17.pdf